KATRIN KAHL: Open Payments
NPI 1730664723 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 43 payments from 10 companies in 2025. Trend: 2023 $137 · 2024 $76 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $262 |
| Vanda Pharmaceuticals Inc. | 16 | $218 |
| Exact Sciences Corporation | 2 | $51 |
| Lilly USA, LLC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Novo Nordisk Inc | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Gilead Sciences, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $16 |
Products named: FANAPT, QULIPTA, VRAYLAR, Cologuard Collection Kit, UBRELVY, CAPLYTA, MAVYRET, AIRSUPRA.
Industry payments across MT — which companies pay providers there.
